These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6862728)

  • 21. Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
    Rosenberg M; Zugck C; Nelles M; Juenger C; Frank D; Remppis A; Giannitsis E; Katus HA; Frey N
    Circ Heart Fail; 2008 May; 1(1):43-9. PubMed ID: 19808269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms facilitating oxygen delivery during exercise in patients with chronic heart failure].
    Agostoni P; Assanelli E; Guazzi M; Grazi M; Perego GB; Lomanto M; Cattadori G; Lauri G; Marenzi G
    Cardiologia; 1997 Jul; 42(7):743-50. PubMed ID: 9270180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy.
    Cunha AB; Cunha DM; Pedrosa RC; Flammini F; Silva AJ; Saad EA; Kopiler DA
    Rev Port Cardiol; 2003 Jan; 22(1):29-52. PubMed ID: 12712809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure scheduled for cardiac resynchronization therapy.
    Goette A; Jentsch-Ullrich K; Hammwöhner M; Trautmann S; Franke A; Klein HU; Auricchio A
    Europace; 2006 Mar; 8(3):157-60. PubMed ID: 16627431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol plasma binding and serum lipids during chronic therapy in migraine patients.
    Albani F; Riva R; Cortelli P; Contin M; Baruzzi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):267-9. PubMed ID: 4008116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical consequences of pharmacokinetic properties of cardiac glycosides.
    Kochsiek K
    Eur Heart J; 1982 Dec; 3 Suppl D():79-86. PubMed ID: 6761130
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
    Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum protein binding of model acidic drugs in smokers and non-smokers.
    Ruiz-Cabello F; Erill S
    Int J Clin Pharmacol Res; 1986; 6(3):177-9. PubMed ID: 3744622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protein-bound and butanol-extracted serum iodine levels in patients with chronic cardiac insufficiency].
    Beliaeva AP
    Ter Arkh; 1971 Nov; 43(11):75-8. PubMed ID: 5149232
    [No Abstract]   [Full Text] [Related]  

  • 34. Protein binding properties of prazosin.
    Hobbs DC; Twomey TM
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):189-92. PubMed ID: 451356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat treatment of human serum to inactivate HIV does not alter protein binding of selected drugs.
    Mosley AK; Brouwer KL
    Ther Drug Monit; 1997 Aug; 19(4):477-9. PubMed ID: 9263392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postburn serum drug binding and serum protein concentrations.
    Bloedow DC; Hansbrough JF; Hardin T; Simons M
    J Clin Pharmacol; 1986 Feb; 26(2):147-51. PubMed ID: 3950058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intestinal absorption of fats in patients with chronic circulatory failure].
    Florkiewicz H; Tarkowska A; Rumiński W
    Wiad Lek; 1978 Jan; 31(1):1-5. PubMed ID: 565981
    [No Abstract]   [Full Text] [Related]  

  • 38. Imipramine serum protein binding in healthy subjects.
    Kristensen CB
    Clin Pharmacol Ther; 1983 Nov; 34(5):689-94. PubMed ID: 6627829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum protein binding of salicylates in chronic circulatory insufficiency].
    Tikhonov VP
    Ter Arkh; 1972 Apr; 44(4):83-6. PubMed ID: 5051563
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in some physico-chemical properties of the serum proteins in patients with chronic insufficiency of the blood circulation].
    Klykov NV; Nikolov SKh; Nefedov PV
    Ter Arkh; 1968 Sep; 40(9):102-5. PubMed ID: 5739659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.